Bayer Pharma AG
Bayer Pharma AG, a leading global pharmaceutical company headquartered in Germany, is renowned for its innovative contributions to healthcare. Founded in 1863, Bayer has established a strong presence in major operational regions, including Europe, North America, and Asia. The company primarily focuses on prescription pharmaceuticals, consumer health products, and biotechnology, with a commitment to advancing medical science. Bayer's core offerings include treatments for cardiovascular diseases, oncology, and women's health, distinguished by their cutting-edge research and development. With a robust portfolio of unique products, Bayer has achieved significant market position, consistently ranking among the top pharmaceutical companies worldwide. Notable milestones in its history reflect a dedication to improving patient outcomes and addressing global health challenges.
DitchCarbon Score
How does Bayer Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bayer Pharma AG's score of 56 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bayer Pharma AG's reported carbon emissions
Bayer Pharma AG, headquartered in Germany (DE), currently does not provide specific carbon emissions data or reduction targets. Without available figures on their emissions, it is challenging to assess their current environmental impact or commitments. However, the company is likely engaged in various climate initiatives typical of the pharmaceutical industry, focusing on sustainability and reducing their carbon footprint. As the industry increasingly prioritises climate action, Bayer Pharma AG may be working towards aligning with global standards and frameworks to enhance their environmental performance. Further details on their specific commitments or initiatives would be necessary to provide a comprehensive overview.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bayer Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
